Literature DB >> 2983801

Two distinct corticotrophin releasing activities of vasopressin.

J C Buckingham.   

Abstract

The effect of various corticotrophin releasing factors (CRFs) on the secretion of corticotrophin (ACTH) by segments of rat anterior pituitary tissue has been studied in vitro. ACTH release was stimulated by CRF-41 (5.0 X 10(-9) - 2.0 X 10(-7) M), hypothalamic extracts (0.2 - 1.6 HE ml-1) and arginine vasopressin (AVP, 5.0 X 10(-9) - 8.0 X 10(-7) M). The slopes of the dose-response lines of CRF-41 were greater than those of AVP, less than those of hypothalamic extracts from control animals and resembled those of hypothalamic extracts from Brattleboro rats. Simultaneous addition of AVP (10(-10) M) to the incubation medium enhanced the response to CRF-41 and increased the slope of its dose-response lines. The adrenocorticotrophic response to CRF-41 was enhanced similarly by pretreatment of the tissue with AVP (1.25 X 10(-11) - 2.0 X 10(-10) M) as also was the response to hypothalamic extracts. In contrast, pretreatment of the tissue with CRF-41 (2.3 X 10(-11) - 2.3 X 10(-8) M) depressed the subsequent response to CRF-41 and to hypothalamic extracts. The marked difference between the concentrations of vasopressin required to facilitate maximally the response to CRF-41 and those necessary to evoke ACTH release suggests that the two effects may be mediated by different types of vasopressin receptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983801      PMCID: PMC1987216     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

Review 1.  CELLULAR AND MOLECULAR ASPECTS OF THE ANTIDIURETIC ACTION OF VASOPRESSINS AND RELATED PEPTIDES.

Authors:  I L SCHWARTZ; L M LIVINGSTON
Journal:  Vitam Horm       Date:  1964       Impact factor: 3.421

2.  The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors.

Authors:  J C Buckingham; J R Hodges
Journal:  J Endocrinol       Date:  1977-02       Impact factor: 4.286

3.  The cytochemical section assay for corticotrophin.

Authors:  J Alaghband-Zadeh; J R Daly; L Bitensky; J Chayen
Journal:  Clin Endocrinol (Oxf)       Date:  1974-07       Impact factor: 3.478

4.  Corticotrophin releasing factor may be modulated vasopressin.

Authors:  G Gillies; P Lowry
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

5.  In vivo adrenocorticotropin-releasing activity of neurohypophyseal hormones and their analogs.

Authors:  T Aizawa; N Yasuda; M A Greer; W H Sawyer
Journal:  Endocrinology       Date:  1982-01       Impact factor: 4.736

6.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

7.  New category of vasopressin receptor in the central nervous system. Evidence that this receptor mediates the release of a humoral factor VIII-mobilizing principle.

Authors:  J H Cort; A J Fischman; W J Dodds; J H Rand; I L Schwartz
Journal:  Int J Pept Protein Res       Date:  1981-01

8.  The influence of vasopressin on hypothalamic corticotrophin releasing activity in rats with inherited diabetes insipidus.

Authors:  J C Buckingham
Journal:  J Physiol       Date:  1981-03       Impact factor: 5.182

9.  Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus.

Authors:  J C Buckingham; J H Leach
Journal:  J Physiol       Date:  1980-08       Impact factor: 5.182

10.  Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.

Authors:  B Lutz-Bucher; B Koch; C Mialhe
Journal:  Neuroendocrinology       Date:  1977       Impact factor: 4.914

View more
  1 in total

Review 1.  Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.